Pink Sheet: global policy and regulatory coverage
The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.
Find out who’s leading the pack in Oncology drug development, and take a closer look at where the highest success rates are by viewing our webinar recording on Oncology Success Rates.
Effectively manage your portfolio risk by using the comprehensive data sets, including Probability of Overall Success (POS), Likelihood of Approval (LOA), and Phase and Overall Duration, in Pharmapremia. Covering over 500 indications and 7,000 programs, including over 2,200 in oncology, Pharmapremia allows you to generate customized intelligence reports tailored to your company’s goals and needs.
Watch the recording below today!
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
In Vivo: strategic insights for life sciences decision-maker...
Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: